Related Experiment Video

Updated: Aug 17, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Antigen-specific CD8+ T lymphocytes generated from a DNA vaccine control tumors through the Fas-FasL pathway

Wen-Fang Cheng1, Chien-Nan Lee, Ming-Cheng Chang

  • 1Department of Obstetrics and Gynecology, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|June 28, 2005
PubMed

Insights

A novel DNA vaccine targeting human papillomavirus type 16 E7 protein demonstrated significant antitumor effects against cervical cancer models. This approach overcomes immune evasion by Fas downregulation, highlighting the Fas-FasL pathway

Area of Science:

  • Oncology
  • Immunology
  • Vaccine Development

Background:

  • Human papillomavirus (HPV), particularly type 16, and its oncogenic proteins E6 and E7 are implicated in cervical cancer.
  • Cancer immune evasion often involves downregulating Fas molecules, hindering cytotoxic T lymphocyte (CTL) responses.
  • A murine model (TC-1 P3(A15) tumors) with E7 expression and downregulated Fas was developed to study immunotherapy resistance.

Purpose of the Study:

  • To evaluate the efficacy of a chimeric calreticulin-E7 (CRT/E7) DNA vaccine against tumors with downregulated Fas expression.
  • To elucidate the mechanism of action for the CRT/E7 DNA vaccine, focusing on CD8+ T lymphocyte responses and the Fas-FasL pathway.

Main Methods:

  • Development of a murine tumor model (TC-1 P3(A15)) expressing HPV16 E7 and exhibiting Fas downregulation.
  • Administration of a DNA vaccine encoding calreticulin linked to E7 (CRT/E7).
  • In vitro antibody depletion and in vivo adoptive transfer experiments to assess CD8+ T lymphocyte function and the role of the Fas-FasL pathway.

Main Results:

  • The CRT/E7 DNA vaccine conferred protective and therapeutic antitumor effects against TC-1 P3(A15) tumors.
  • Antitumor activity was mediated by E7-specific CD8+ T lymphocytes through a Fas-FasL-dependent CTL mechanism.
  • Tumor cells with downregulated Fas expression required higher numbers of antigen-specific CD8+ T lymphocytes for elimination, underscoring the importance of Fas in immune evasion.

Conclusions:

  • Chimeric CRT/E7 DNA vaccine effectively controls tumors that downregulate Fas expression.
  • The Fas-FasL pathway is crucial for the potent antitumor effect of antigen-specific CD8+ cytotoxic T lymphocytes.
  • Fas plays a significant role in tumor evasion strategies, and targeting it can enhance immunotherapy efficacy.

More Related Videos

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...